Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole TDM vs Standard Dosing in Invasive Mould Infection
NCT01416025Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Jan 2012
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of voriconazole in invasive mould infection (IMI), sponsored by Johns Hopkins University. Started Jan 2012; status: completed.
02
Drugs
voriconazole
03
Conditions
invasive mould infection (IMI)
Beyond the preview
Go deeper on NCT01416025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01416025.